Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

April 22 Skadden’s Jay Neukom has been named a Top Intellectual Property Lawyer in California by the Daily Journal, in recog… twitter.com/i/web/status/1…
April 22 SEC Proposes Securities Offering Reforms for Business Development Companies and Registered Closed-End Investment Co… twitter.com/i/web/status/1…
April 19 Counsel Ken Kumayama and associate Shaya Afshar highlight issues for attorneys to consider relating to artificial i… twitter.com/i/web/status/1…